Fortress Biotech Appoints Lucy Lu, M.D. to Board of Directors

Fortress Biotech, Inc.

Lucy Lu, M.D. appointed to Fortress Biotech Board effective December 14, 2022.
Dr. Lu previously served as Fortress CFO (2012-2017) and CEO of subsidiary Avenue Therapeutics.
She brings over 20 years of biotech finance and drug development experience including roles at Citigroup.
Standard-form indemnification agreement entered with Dr. Lu, consistent with other directors' terms.

item 1.01 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Lucy Lu, M.D.

Director

FBIO · Fortress Biotech, Inc.

Effective: 2022-12-14
Filed: December 19, 2022, 6:59 PM ET

On December 14, 2022, the Board of Directors (the “Board”) of the “Company elected Lucy Lu, M.D. as a new member of the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Lucy Lu, M.D. was elected as Director at Fortress Biotech, Inc..

Action: elected
Role: Director

Exact text from the filing

On December 14, 2022, the Board of Directors (the “Board”) of the “Company elected Lucy Lu, M.D. as a new member of the Board.

View on SEC.gov

Fortress Biotech, Inc. filing history →

Source: SEC EDGAR

accession 0001558370-22-018778

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.